116 results about "Class Mammalia" patented technology

The current invention provides a biocompatible energy recharge system to normalize body functions for a mammal. Both stationary and circulatory scalar wave energy was produced and utilized to enable the entire body of a mammal to increase the energy potential of any cell in the body, to promote cell growth, to facilitate cell repair, and to reduce cell destruction, hence the cells, organs, systems and the entire body of a mammal become healthy, and to treat a disease or disorder. The invention is a combination of the generators of the three-dimensional bio-waves in the stationary and in the circulationary formats for empowering the cells in all parts of a mammal, and a method of using the 3D bio-waves uniformly to empower each organ of a mammal to restore and maintain the normal body health and function.

The invention relates to the veterinary field and, more particularly, non-rinsed compositions comprising an active ingredient obtained from Ophiopogon Japonicus, panthenol and saccharide isomerate, for non-human mammals. The invention also relates to a method for treating the fur of non-human mammals by applying said non-rinsed compositions to the fur and / or the skin.

The invention relates to a transfer assembly (1) intended to be integrated into a device suitable for transferring, into a female mammal, material or substance for reproductive, therapeutic or diagnostic purposes contained in the internal space of a straw, characterized in that the assembly (1) comprises: a protective sheath (5) having open proximal and distal ends (5b) and an internal axial conduit (50) extending between the proximal and distal ends (5b);and a connecting element (4) integral with the sheath (5) and introduced axially into the conduit (50), the connecting element (4) being a hollow body having open proximal (4a) and distal (4b) ends and a longitudinal passage (6) extending between the proximal (4a) and distal (4b) ends, the connecting element (4) comprising a proximal portion (40) intended to cooperate with the straw and a distal portion (41) intended to cooperate with the proximal end of an inner sheath of the device, the proximal portion (40) comprising means for retaining the straw. Figure to be published with the abbreviation: Figure 5.;

Methods for improving quality of life and / or increasing activity in an aging and / or chronically ill mammal via administration of a composition of egg powder protein are provided.

This document relates to methods and materials involved in assessing and / or treating mammals having a caveolinopathy disease (e.g., immune-mediated rippling muscle disease (iRMD)). For example, methods and materials for detecting the presence of an autoantibody specific for a caveolae-associated protein 4 (cavin-4) polypeptide to identify a mammal as having iRMD as well as methods for treating a mammal identified having iRMD are provided. In some cases, cavin-4 polypeptides (and / or fragments thereof and / or variants thereof) can be used to detect the presence or absence of anti-cavin-4 polypeptide autoantibodies indicative of iRMD.

The invention discloses application of spermidine in preparation of a preparation for improving fertility of female mammals, and belongs to the technical field of reproductive biology. According to the invention, spermidine with different concentrations is introduced into mice, and the effect of spermidine on ovarian hormone secretion, ovarian reserve level and follicle number of female mammals is determined in a diet intake manner, so that the fertility of female animals is improved; it is found that spermidine can effectively improve the ovarian function, increase the secretion level of E2, P4, LH and AMH hormones closely related to the ovarian function, reduce the number of atresia follicles of the ovarian and increase the litter birth number of female mice by 1-2, and the spermidine has good animal breeding and livestock raising application prospects.

The present invention relates to the field of mammalian reproduction and use of a GnRH antagonist in the regulation and control of estrus of a mammal. The GnRH antagonist can inhibit oestrus for a longer time with less frequent use, and can be used for estrus synchronization and batch reproduction of livestock husbandry animals or regulation and control of estrus of pets.

To provide a mammalian epilepsy model.SOLUTION: A mammalian epilepsy model is obtained by a method comprising (i) injecting an RNA-interfering shRNA having a specific nucleic acid sequence of a nucleic acid encoding CREB-controlled transcriptional coactivator 1 into three or more different brain or cranial nerve regions of a mammal; or (ii) injecting an RNA-interfering shRNA having a specific nucleic acid sequence of a nucleic acid encoding CREB-controlled transcriptional coactivator 1 into two or more different brain or cranial nerve regions of a mammal and injecting an RNA-interfering shRNA having a specific nucleic acid sequence of a nucleic acid encoding CREB-controlled transcriptional coactivator 1 into one or more different brain or cranial nerve regions of a mammal.SELECTED DRAWING: None

The present disclosure is directed to a method and device to determine a value of a blood constituent of a mammal. The device includes a plurality of light emitting diodes, one or more sensors and a processor.

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for improving mood in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

Accordingly, in its first aspect, the present invention relates to a method for fitting clothing items to the anatomical geometry of animal body parts and comprising the steps of: Positioning mammal in a comfortable, free and unforced position; or in a controlled position that forces the exposure of important anatomical features; or in a sequence of movements enforcing the above position to be adopted in a predictable future moment; or in a position with controlled placement in relation to surroundings objects such as floor, walls; Starting a data collection device equipped with an optical system for collecting optical data in essentially real time and configured to communicate with an operator of the device with an at least graphical user interface; Placement of the data collection device basically perpendicularly to the mammal body part axis and in a distance enabling the collection of the optical data about the whole body part and / or surroundings objects; Collection of the optical data; Automatic or manual determining the type of mammal, part of the body visible to the optical system and determining a set of biometric indicators necessary to determine the anatomical geometry of a certain body part of given animal; Presenting in real time the gathered optical data on the electronic interface and indicating to the operator found biometric indicators.

The use of FcγRIIB as a mammalian mammary IgG transport receptor. By constructing FcγRIIB-knockout mice and FcγRIIB-knockout pigs, it is found that the ratio of serum and milk IgG concentrations of the FcγRIIB-knockout mice is significantly increased, that is, the relative concentration of milk IgG is reduced; and the FcγRIIB-knockout pigs have a significantly increased serum IgG content, but IgG is nearly undetectable in colostrum. Therefore, it has been proved for the first time that FcγRIIB is a receptor that mediates the trans-mammary transport of serum IgG to milk, and answers a long-term unsolved problem in the field of maternal passive immunity research. Furthermore, a new strategy is provided for increasing the IgG content of colostrum, thereby improving the early immunity and survival rate of neonatal domestic animals.

This disclosure generally relates to an optical coherence tomography (OCT) system. This disclosure particularly relates to an OCT system with a multi-pass dispersion compensation cell incorporated into its reference arm. This disclosure further relates to a hand-held compact OCT system suitable for inspection of an ear of a mammal.

The present disclosure provides methods of treating factor X deficiency with fitusiran in a mammal in need thereof.

Pharmaceutical compositions, and methods of production and use for the treatment of neoplastic disease in a mammalian animal. When administered to an animal, the pharmaceutical compositions are useful for the treatment of neoplastic diseases such as various cancers, particularly those affecting mammalian animals such as companion animals.

The present invention relates to dispensing instruments and methods for introducing treatment material and fluid-like material with an embryo into a uterus. More specifically, the present invention relates to apparatuses for delivering a fertilized egg or embryo into a maternal uterine endometrium in humans or any other mammalian species and associated computer programs for controlling said apparatuses.

Pharmaceutical compositions, and methods of production and use for the treatment of neoplastic disease in a mammalian animal. When administered to an animal, the pharmaceutical compositions are useful for the treatment of neoplastic diseases such as various cancers, particularly those affecting mammalian animals such as companion animals.

Provided herein are methods for preventing or treating diseases, said methods comprising (i) inhibiting entry of bacteriophages and / or component(s) thereof into microbiota, bodily fluid(s) or tissue(s) of the mammals and / or (ii) inactivating or modifying bacteriophages and / or component(s) thereof present in microbiota, bodily fluid(s) or tissues of the mammals and / or (iii) inactivating or modifying bacteriophages and / or component(s) thereof in one or more of food, drinking water, water for washing, water for air humidification, air, or habitat object of the mammals.

This document relates to methods and materials involved in assessing and / or treating a mammal having cancer (e.g., lymphoma). For example, methods and materials that can be used to determine if a mammal (e.g., a human) having cancer (e.g., lymphoma) is likely to respond to or has a cancer or a gut microbiome that makes that mammal more responsive to a particular cancer treatment are provided. Methods and materials for treating a mammal having cancer (e.g., lymphoma) are also provided.

The present invention relates to a method and equipment to record brainwave signals and / or behavioral response in a mammal, analyze recorded signals or behavioral response for parameters, and determine whether the mammal was in an altered mental state at the time of brainwave signal recording. The record signals are analyzed for power, onset time, modulation of magnitude, accumulation, or persistence, modulation of intrinsic timescale, or changes in phase locking and population dynamics. The behavioral response is time to eye closure after an air puff into the eye. The recorded signals and the behavioral response are biomarkers that can be independently detected for determination of an altered mental state in a mammal.

The present invention relates to the field of mammalian reproduction. Disclosed is use of a GnRH antagonist in the regulation and control of estrus of a mammal. The GnRH antagonist can inhibit oestrus for a longer time with less frequent use, and can be used for estrus synchronization and batch reproduction of livestock husbandry animals or regulation and control of estrus of pets.

The present application is to provide a method for evaluating the potential risk of a mammal suffering from a disease and / or whether the mammal is potentially healthy using a predetermined quantitative value and / or a value of a weight ratio of collagen contained in the teeth of the mammal as an index. The solution is to compare at least any one of respective reference values of PYD, PEN, T-Glyc, PpP and PpG of collagen contained in the teeth of a mammal to be evaluated for the potential risk of suffering from a disease and / or whether the mammal is potentially healthy, and collagen contained in the teeth of one or more mammals selected from a mammal not suffering from a disease, a mammal suffering from a disease, a healthy mammal and an unhealthy mammal.

The present invention relates to an oily composition comprising maropitant and an oily carrier. The invention also relates to the use of such a composition in the treatment and prevention of nausea and vomiting in a non-human mammal, in particular a dog or cat.

An electronic device for long-term adhesion to a mammal includes a housing with an electronic component. The electronic device may include a first wing and a second wing, each being integrally formed with the housing. An electrode is positioned on a bottom surface of each of the wings, the electrodes electrically connected to the electronic component. An adhesive layer is provided for adhesion to a surface of the mammal. The adhesive layer may cover a portion of the bottom surfaces of the wings but generally does not cover the electrode or a bottom surface of the housing. A method of applying an electronic device to a mammal includes removing first and second adhesive covers from first and second wings of the electronic device to expose an electrode and an adhesive coated on a bottom surface of each wing.

The present disclosure relates to a wearable monitor device and methods and systems for using such a device. In certain embodiments, the wearable monitor records cardiac data from a mammal and extracts particular features of interest. These features are then transmitted and used to provide health-related information about the mammal.

The present invention relates to the veterinary field and, more particularly, to shampoo compositions comprising an active ingredient obtained from Ophiopogon japonicus and an amphoteric surfactant, for non-human mammals. The invention also relates to a method for washing the coat of non-human mammals by applying said shampoo compositions to the coat and / or the skin.

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to improve and or reduce insomnia, improve total sleep duration and quality, improve deep sleep duration and time in light sleep, improve sleep latency, improve the amount of time awake and improve sleep efficiency, readiness and balance in a mammal.

A medical tissue wrap, for an internal anatomical structure of a mammal is formed by a coiled wall having a circumferential inner end portion and a circumferential outer end portion extending around and overlapping the circumferential inner end portion. The wall thereby defines a longitudinal through-hole for accommodating a portion of the anatomical structure. The circumferential outer end portion is radially spaced-apart from the circumferential inner end portion by a discontinuous spacing in the circumferential direction. The tissue wrap comprises a structural outer surface modification at opposing longitudinal end portions of its wall.

Methods and compositions are disclosed for inducing immune responses against one or more antigens in a mammal.